Quality Outlook Blog: Aligning Quality Measurement with Oncology Innovation

December 2019

In the latest installment of Discern Health’s Quality Outlook blog series in the Journal of Clinical Pathways (JCP), Partner Tom Valuck and Directors David Blaisdell and Theresa Schmidt highlight the challenge of keeping quality measures up to date as new evidence and guidelines are rapidly updated and breakthrough treatments transform clinical practice.

Catch Me If You Can: Aligning Quality Measurement with Oncology Innovation” is Discern’s second blog post in the Quality Outlook series, which explores key issues in oncology quality and value through articles focused on measurement, value-based payment, and quality improvement. This blog installment is also featured as a Viewpoint article in the JCP December print issue.

Read the blog post here. Read other Quality Outlook posts here.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO